Increasing trust in real-world evidence through evaluation of observational data quality

被引:50
|
作者
Blacketer, Clair [1 ,2 ]
Defalco, Frank J. [1 ]
Ryan, Patrick B. [1 ,3 ]
Rijnbeek, Peter R. [2 ]
机构
[1] Janssen Res & Dev LLC, Observat Hlth Data Analyt, 1125 Trenton Harbourton Rd, Titusville, NJ 08560 USA
[2] Erasmus MC, Dept Med Informat, Rotterdam, Netherlands
[3] Columbia Univ, Dept Biomed Informat, New York, NY USA
关键词
Data Quality; Data Standardization; Common Data Model; Real World Evidence;
D O I
10.1093/jamia/ocab132
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective: Advances in standardization of observational healthcare data have enabled methodological breakthroughs, rapid global collaboration, and generation of real-world evidence to improve patient outcomes. Standardizations in data structure, such as use of common data models, need to be coupled with standardized approaches for data quality assessment. To ensure confidence in real-world evidence generated from the analysis of real-world data, one must first have confidence in the data itself. Materials and Methods: We describe the implementation of check types across a data quality framework of conformance, completeness, plausibility, with both verification and validation. We illustrate how data quality checks, paired with decision thresholds, can be configured to customize data quality reporting across a range of observational health data sources. We discuss how data quality reporting can become part of the overall realworld evidence generation and dissemination process to promote transparency and build confidence in the resulting output. Results: The Data Quality Dashboard is an open-source R package that reports potential quality issues in an OMOP CDM instance through the systematic execution and summarization of over 3300 configurable data quality checks. Discussion: Transparently communicating how well common data model-standardized databases adhere to a set of quality measures adds a crucial piece that is currently missing from observational research. Conclusion: Assessing and improving the quality of our data will inherently improve the quality of the evidence we generate.
引用
收藏
页码:2251 / 2257
页数:7
相关论文
共 50 条
  • [11] INSIGHT: A Tool for Fit-for-Purpose Evaluation and Quality Assessment of Standardized Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety
    Hoxhaj, Vjola
    Navarro, Constanza L. Andaur
    Riera-Arnau, Judit
    Elbers, Roel J. H. J.
    Alsina, Ema
    Dodd, Caitlin
    Sturkenboom, Miriam C. J. M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2025, 34 (01)
  • [12] Real-World Data and Evidence in Lung Cancer: A Review of Recent Developments
    Kokkotou, Eleni
    Anagnostakis, Maximilian
    Evangelou, Georgios
    Syrigos, Nikolaos K.
    Gkiozos, Ioannis
    CANCERS, 2024, 16 (07)
  • [13] The use of real-world data/evidence in regulatory submissions
    Song, Fuyu
    Zang, Chenxuan
    Ma, Xinyi
    Hu, Sifan
    Sun, Qiqing
    Chow, Shein-Chung
    Sun, Hongqiang
    CONTEMPORARY CLINICAL TRIALS, 2021, 109
  • [14] Leveraging Real-World Evidence and Observational Studies in Treating Multiple Sclerosis
    Aboseif, Albert
    Roos, Izanne
    Krieger, Stephen
    Kalincik, Tomas
    Hersh, Carrie M.
    NEUROLOGIC CLINICS, 2024, 42 (01) : 203 - 227
  • [15] Real-World Evidence: Integrating Machine Learning with Real-World Big Data for Predictive Analytics in Healthcare
    Vecchio, Nicolas
    CARDIOLOGY, 2024,
  • [16] Real-World Evidence of COVID-19 Patients' Data Quality in the Electronic Health Records
    Binkheder, Samar
    Asiri, Mohammed Ahmed
    Altowayan, Khaled Waleed
    Alshehri, Turki Mohammed
    Alzarie, Mashhour Faleh
    Aldekhyyel, Raniah N.
    Almaghlouth, Ibrahim A.
    Almulhem, Jwaher A.
    HEALTHCARE, 2021, 9 (12)
  • [17] Contributions of Real-World Evidence and Real-World Data to Decision-Making in the Management of Soft Tissue Sarcomas
    Demetri, George D.
    Stacchiotti, Silvia
    ONCOLOGY, 2021, 99 (SUPPL 1) : 3 - 7
  • [18] Increase transparency and reproducibility of real-world evidence in rare diseases through disease-specific Federated Data Networks
    van Baalen, Valerie
    Didden, Eva-Maria
    Rosenberg, Daniel
    Bardenheuer, Kristina
    van Speybroeck, Michel
    Brand, Monika
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (04)
  • [19] Real-world data: A relevant component in the framework of scientific evidence
    Canonica, Giorgio W.
    Del Moro, Lorenzo
    Costanzo, Giovanni
    Nappi, Emanuele
    Paoletti, Giovanni
    ASIA PACIFIC ALLERGY, 2023, 13 (01) : 40 - 43
  • [20] Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"
    Paoletti, Giovanni
    Di Bona, Danilo
    Chu, Derek K.
    Firinu, Davide
    Heffler, Enrico
    Agache, Ioana
    Jutel, Marek
    Klimek, Ludger
    Pfaar, Oliver
    Moesges, Ralph
    DunnGalvin, Audrey
    Genuneit, Jon
    Hoffmann, Hans Jurgen
    Canonica, Giorgio Walter
    ALLERGY, 2021, 76 (09) : 2663 - 2672